Literature DB >> 8662134

Update on the mechanisms of immune suppression of injury and immune modulation.

E Faist1, C Schinkel, S Zimmer.   

Abstract

Major trauma results in massive impairment of immunologic reactivity, the clinical consequence of which consists in the high susceptibility of the traumatized individual toward serious infection. Whereas parts of the immune system are stimulated within a systemic, nondiscriminant, excessive whole-body inflammation, other functions within the complex of cell-mediated immunity (CMI) are dramatically paralyzed. Immune abnormalities in the aftermath of trauma occur in a sequence of states of cellular activation and within a complex order of events that is not yet well understood. Traumatic stress is causing disintegration of the intact monocyte (Mphi)-T cell interaction, which is associated with profound changes in Mphi forward-regulatory capacities and substantial depression of T cell function. Extensive tissue destruction results in the generation of numerous stimuli, such as phagocytosis, immune complexes, complement split products, and endo- and exotoxins, all of which contribute to excessive Mphi activation. Mphi then rapidly produce and release prostaglandin E2 (PGE2), a powerful endogenous immune suppressant. PGE2 is an inhibitor of T cell mitogenesis, interleukin 2 (IL-2) production, and IL-2 receptor expression; and it has a massive impact on the quality of B cell antibody synthesis. Most importantly, PGE2 represents an important cofactor for the induction of T-helper lymphocyte (TH) activity toward the TH2 direction. TH2 cells are associated with the synthesis of immunosuppressive cytokines, such as IL-4 and IL-10. Although immunosuppressive substrates are inhibitory for TH1 cells-the functional carriers of CMI-they support TH2 activity, which predisposes the host to develop infection. The endogenous ability of the organism to survive overwhelming trauma is insufficient and requires major exogenous support. Immune modulatory interventions, depending on the immune abnormalities seen in the traumatized host, should be started as early as possible after trauma in a preventive fashion to protect against organ tissue destruction. Ideally, it should protect all cellular host defense compartments from hyperactivation as well as from exhaustion. We do believe that only a combination of drugs can effectively control the posttraumatic dyshomeostasis of the various cell systems.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662134     DOI: 10.1007/s002689900071

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  49 in total

1.  Natural antibodies in childhood: development, individual stability, and injury effect indicate a contribution to immune memory.

Authors:  P Mirilas; C Fesel; B Guilbert; N G Beratis; S Avrameas
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

2.  Modulation of immune responses and suppression of experimental autoimmune myasthenia gravis by surgical denervation of the spleen.

Authors:  M Bakhiet; L-Y Yu; V Ozenci; A Khan; F-D Shi
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

Review 3.  Overtraining, excessive exercise, and altered immunity: is this a T helper-1 versus T helper-2 lymphocyte response?

Authors:  Lucille Lakier Smith
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 4.  [Value of laparoscopic liver resection].

Authors:  M R Schön
Journal:  Chirurg       Date:  2010-06       Impact factor: 0.955

5.  Differing activation status and immune effector molecule expression profiles of neonatal and maternal lymphocytes in an African population.

Authors:  Ilka Engelmann; Ulrike Moeller; Andrea Santamaria; Peter G Kremsner; Adrian J F Luty
Journal:  Immunology       Date:  2006-09-20       Impact factor: 7.397

Review 6.  A role for corticosterone in impaired intestinal immunity and barrier function in a rodent model of acute alcohol intoxication and burn injury.

Authors:  Mashkoor A Choudhry; Xiaoling Li; Irshad H Chaudry
Journal:  J Neuroimmune Pharmacol       Date:  2006-12       Impact factor: 4.147

7.  Expression of complement receptor type 1 (CR1) on erythrocytes of paracoccidiodomycosis patients.

Authors:  J E Teixeira; R Martinez; L M Câmara; J E Barbosa
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

8.  Adherence to the ERAS protocol is Associated with 5-Year Survival After Colorectal Cancer Surgery: A Retrospective Cohort Study.

Authors:  Ulf O Gustafsson; Henrik Oppelstrup; Anders Thorell; Jonas Nygren; Olle Ljungqvist
Journal:  World J Surg       Date:  2016-07       Impact factor: 3.352

9.  Perioperative recombinant human granulocyte colony-stimulating factor (Filgrastim) treatment prevents immunoinflammatory dysfunction associated with major surgery.

Authors:  Christian Schneider; Sonja von Aulock; Siegfried Zedler; Christian Schinkel; Thomas Hartung; Eugen Faist
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

10.  Primary immune response to keyhole limpet haemocyanin following trauma in relation to low plasma glutamine.

Authors:  P G Boelens; J C M Fonk; A P J Houdijk; R J Scheper; H J T H M Haarman; S Meijer; P A M Van Leeuwen; B M E von Blomberg-van der Flier
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.